The drug has been shown to be nearly one hundred percent effective in curing all known viruses. Its existence is proprietary information. A critical side-effect is that approximately seventy-five percent of the test subjects have died. The drug is administered intravenously.
The first human subject to be injected with SODRA was Peter Farragut, in Single Strand. After 2 hours and 36 minutes and two doses of SODRA, the drug managed to stabilise the NARVIK-B infection. However, after a short period, the NARVIK-B strain managed to overcome even SODRA - killing Peter Farragut.